Gyre Therapeutics, Inc. (GYRE) Revenue History
Gyre Therapeutics, Inc. (GYRE) annual revenue history. Get revenue data in Excel with MarketXLS.
Revenue Data
| Period | Revenue (USD) |
|---|---|
| 2016-12-31 | $399.00K |
| 2017-12-31 | $1.02M |
| 2018-12-31 | $6.00K |
| 2019-12-31 | N/A |
| 2020-12-31 | $20.95M |
| 2021-12-31 | $7.34M |
| 2022-12-31 | $102.29M |
| 2023-12-31 | $113.45M |
| 2024-12-31 | $105.76M |
| 2025-12-31 | $116.59M |
How GYRE compares with sector peers
| Symbol | Company | Revenue (latest fiscal year) |
|---|---|---|
| STIM | Neuronetics Inc. | $149.16M |
| NRC | National Research Corporation | $137.39M |
| OSUR | OraSure Technologies Inc. | $115.02M |
| AGEN | Agenus Inc. | $114.20M |
| HBIO | Harvard Bioscience Inc. | $86.55M |
These are five companies in the same sector as GYRE with a comparable annual revenue. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Gyre Therapeutics, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue("GYRE", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | GYRE | $6.91 | -1.57% | 0.07M |
| 3 | ||||
| 4 | ||||
| 5 |